BRIEF-Outlook Therapeutics Streamlines Operations

Reuters12-14

Dec 13 (Reuters) - Outlook Therapeutics Inc :

* OUTLOOK THERAPEUTICS® STREAMLINES OPERATIONS

* OUTLOOK THERAPEUTICS INC - IMPLEMENTS INITIATIVES TO STREAMLINE ORGANIZATION AND REDUCE EXPENSES

* OUTLOOK THERAPEUTICS INC - ANNOUNCES 23% WORKFORCE REDUCTION, $1.4 MILLION ANNUAL SAVINGS

* OUTLOOK THERAPEUTICS INC - TO RESUBMIT BLA APPLICATION FOR ONS-5010 IN Q1 2025

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491585525?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-14 05:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491585525","market":"us","top_or_hot":-1,"title":"BRIEF-Outlook Therapeutics Streamlines Operations","media":"Reuters","content":"<html><body><p>Dec 13 (Reuters) - Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * OUTLOOK THERAPEUTICS® STREAMLINES OPERATIONS</p><p>   * OUTLOOK THERAPEUTICS INC - IMPLEMENTS INITIATIVES TO STREAMLINE ORGANIZATION AND REDUCE EXPENSES</p><p>   * OUTLOOK THERAPEUTICS INC - ANNOUNCES 23% WORKFORCE REDUCTION, $1.4 MILLION ANNUAL SAVINGS</p><p>   * OUTLOOK THERAPEUTICS INC - TO RESUBMIT BLA APPLICATION FOR ONS-5010 IN Q1 2025</p><p>Source text:   Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Outlook Therapeutics Streamlines Operations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Outlook Therapeutics Streamlines Operations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-14 05:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 13 (Reuters) - Outlook Therapeutics Inc   :   * OUTLOOK THERAPEUTICS® STREAMLINES OPERATIONS   * OUTLOOK THERAPEUTICS INC - IMPLEMENTS INITIATIVES TO STREAMLINE ORGANIZATION AND REDUCE EXPENSES   ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2491585525","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491585525","pubTimestamp":1734125499,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Dec 13  - Outlook Therapeutics Inc   :   * OUTLOOK THERAPEUTICS STREAMLINES OPERATIONS   * OUTLOOK THERAPEUTICS INC - IMPLEMENTS INITIATIVES TO STREAMLINE ORGANIZATION AND REDUCE EXPENSES   * OUTLOOK THERAPEUTICS INC - ANNOUNCES 23% WORKFORCE REDUCTION, $1.4 MILLION ANNUAL SAVINGS   * OUTLOOK THERAPEUTICS INC - TO RESUBMIT BLA APPLICATION FOR ONS-5010 IN Q1 2025Source text:   Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics","OTLK":"Outlook Therapeutics, Inc."},"translate_title":"简要展望Therapeutics简化运营","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"OTLK":0.9},"content_text":"Dec 13 (Reuters) - Outlook Therapeutics Inc   :   * OUTLOOK THERAPEUTICS® STREAMLINES OPERATIONS   * OUTLOOK THERAPEUTICS INC - IMPLEMENTS INITIATIVES TO STREAMLINE ORGANIZATION AND REDUCE EXPENSES   * OUTLOOK THERAPEUTICS INC - ANNOUNCES 23% WORKFORCE REDUCTION, $1.4 MILLION ANNUAL SAVINGS   * OUTLOOK THERAPEUTICS INC - TO RESUBMIT BLA APPLICATION FOR ONS-5010 IN Q1 2025Source text:   Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491585525"}